Overview
Status
Active
Registry date
2024-06-21
Share capital
8,000.00 PLN
Registered address
ul. Warszawska 6/32, 15-063 Białystok, Poland
Electronic delivery address
AE:PL-50357-69039-CEVWS-15
Financials
Revenue history (in k)
Filing timeliness
2 of 2 financial statements were filed late (the longest delay 33 days for 2025).
- 202517/08/2026
- 202413/08/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 79.20kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 10.41kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 66.43kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 10.93kMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Aliaksandr Yatsenka – Management Board Member
Małgorzata Siergiejenko – Management Board Member
Vitali Rudz – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Vitali Rudzage 49 | 38 | $513.24 | 23.75% |
Małgorzata Siergiejenkoage 37 | 84 | $1,134.52 | 52.5% |
Aliaksandr Yatsenkaage 48 | 38 | $513.24 | 23.75% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-07-12.
56 1020 1332 0000 1602 1530 5590
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A. | $146,864,520.79 | multipharme.pl | ||
| DiagnosisS.A. | $37,413,735.72 | diagnosis.pl | ||
| Cirrosp. z o.o. | $20,863,166.14 | cirro.pl | ||
| Premmier Redsp. z o.o. | $2,723,178.99 | premmier.com | ||
| Pharmbiopolsp. z o.o. | $99,211.10 | pharmbiopol.com | ||
| Mimic Polandsp. z o.o. | $85,589.70 | mimic.com.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| Toto Pharma Polandsp. z o.o. | $66,269.14 | totopharma.com | ||
| Novaova Sosnowski Wadowskisp. k. | $54,452.69 | novaova.pl | ||
| Temedasp. z o.o. | – | temeda.pl |
FAQ
The main business activity of Labtech Solutions focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on June 21, 2024.
The headquarters is located at: ul. Warszawska 6, 15-063 Białystok.
The share capital of the company is PLN 8,000 (approx. $2,161).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 79,202, representing an increase of 274888.4% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 10,409.
The largest operating cost category falls under other operating costs. This category amounted to USD 66,429 in 2025, representing 100% of all operating expenses.
Last updated: 2026-08-17